1-20 of 76
Lara C. Pullen, PhD
Close
Sort by
News

New Risk Classification Stratifies Outcomes in Older Intensively Treated Patients with AML

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, New Risk Classification Stratifies Outcomes in Older Intensively Treated Patients with AML
News

Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose
News

Patients in R/R Marginal Zone Lymphoma Cohort of ELM-2 Show Superior Outcomes With Odronextamab

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Patients in R/R Marginal Zone Lymphoma Cohort of ELM-2 Show Superior Outcomes With Odronextamab
News

Daratumumab Shows Better Outcomes Than Active Monitoring for Smoldering Multiple Myeloma

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Daratumumab Shows Better Outcomes Than Active Monitoring for Smoldering Multiple Myeloma
News

Analysis Finds CLL-IPI Performs Poorly When Predicting Survival for Patients Treated With Targeted Therapies

Lara C. Pullen, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, Analysis Finds CLL-IPI Performs Poorly When Predicting Survival for Patients Treated With Targeted Therapies
News

CAR-T Therapy Effective for Richter Transformation

Lara C. Pullen, PhD
Published: 2024
Abstract
December Supplement 2024
View News titled, CAR-T Therapy Effective for Richter Transformation
News

Study Reveals Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Study Reveals Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms
News

Socioeconomic Factors, Education Levels Affect Access to AlloHCT

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Socioeconomic Factors, Education Levels Affect Access to AlloHCT
News

Elritercept May Provide Clinically Meaningful Benefits for Patients with MF

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Elritercept May Provide Clinically Meaningful Benefits for Patients with MF
News

Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib
News

Soluble Anti-B-Cell Maturation Antigen, High Disease Burden Modulate Responses in Patients With MM Receiving BCMA T-Cell–Engager Therapy

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Soluble Anti-B-Cell Maturation Antigen, High Disease Burden Modulate Responses in Patients With MM Receiving BCMA T-Cell–Engager Therapy
News

Analysis Offers Insights Into Genetics, Mechanisms of Predisposition to MM

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-November 2024
View News titled, Analysis Offers Insights Into Genetics, Mechanisms of Predisposition to MM
News

Education Program Provides Framework for Thinking About Patient Care in a Rapidly Changing Field

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-November 2024
View News titled, Education Program Provides Framework for Thinking About Patient Care in a Rapidly Changing Field
News

Scientific Program to Present Sessions on Cutting-Edge Topics, Research Advances

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-November 2024
View News titled, Scientific Program to Present Sessions on Cutting-Edge Topics, Research Advances
News

Prognostic Factors and Treatment Outcome in Mycosis Fungoides and Sezary Syndrome

Lara C. Pullen, PhD
Published: 2024
Abstract
October 2024
View News titled, Prognostic Factors and Treatment Outcome in Mycosis Fungoides and Sezary Syndrome
News

Fixed-Duration Regimen Safe, Effective for CLL

Lara C. Pullen, PhD
Published: 2024
Abstract
October 2024
View News titled, Fixed-Duration Regimen Safe, Effective for CLL
News

HCT Shows Better Outcomes in Young Pediatric Patients With Fanconi Anemia

Lara C. Pullen, PhD
Published: 2024
Abstract
September 2024
View News titled, HCT Shows Better Outcomes in Young Pediatric Patients With Fanconi Anemia
News

Cognitive Dysfunction Can Lurk After Remission of Complement-Mediated Thrombotic Microangiopathy

Lara C. Pullen, PhD
Published: 2024
Abstract
September 2024
View News titled, Cognitive Dysfunction Can Lurk After Remission of Complement-Mediated Thrombotic Microangiopathy
News

Researchers Identify Risk Factors for Venous Thromboembolism in Women with Obesity Who Undergo Cesarean Delivery

Lara C. Pullen, PhD
Published: 2024
Abstract
August 2024
View News titled, Researchers Identify Risk Factors for Venous Thromboembolism in Women with Obesity Who Undergo Cesarean Delivery
News

VCDD Combination Therapy Effective for Non-Transplant Eligible Patients With Myeloma

Lara C. Pullen, PhD
Published: 2024
Abstract
August 2024
View News titled, VCDD Combination Therapy Effective for Non-Transplant Eligible Patients With Myeloma